PHASE I DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF ORAL ARTESUNATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (DESPARTH TRIAL)

被引：0
|
作者：
Vandewynckel, Y. -P. [1 ]
Rombauts, K. [2 ]
Verhelst, X. [1 ]
Van Bortel, L. [3 ]
De Spiegeleer, B. [4 ]
Geerts, A. [1 ]
Van Vlierberghe, H. [1 ]
机构：
[1] Univ Ghent, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium
[2] Anticanc Fund, Strombeek Bever, Belgium
[3] Univ Ghent, Fac Pharmaceut Sci, Clin Pharmacol & Pharmacotherapy, B-9000 Ghent, Belgium
[4] Univ Ghent, Fac Pharmaceut Sci, Lab Drug Qual & Registrat, B-9000 Ghent, Belgium
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31522-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1343
引用
收藏
页码：S860 / S860
页数：1
相关论文
共 50 条
  • [41] Phase Ib dose-escalation study of a phase II randomized trial to assess the safety and tolerability of tigatuzumab (CS-1008) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Cheng, Ann-Lii
    Kang, Yoon-Koo
    Ryoo, Baek-Yeol
    Yen, Chia-Jui
    Lim, Ho Yeong
    Oh, Do-Youn
    Austin, TaShara
    Wang, Qiang
    Greenberg, Jonathan
    Beckman, Robert A.
    Kudo, Masatoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors
    Jameson, Gayle S.
    Hamm, John T.
    Weiss, Glen J.
    Alemany, Carlos
    Anthony, Stephen
    Basche, Michele
    Ramanathan, Ramesh K.
    Borad, Mitesh J.
    Tibes, Raoul
    Cohn, Allen
    Hinshaw, Ioana
    Jotte, Robert
    Rosen, Lee S.
    Hoch, Ute
    Eldon, Michael A.
    Medve, Robert
    Schroeder, Katrina
    White, Erica
    Von Hoff, Daniel D.
    CLINICAL CANCER RESEARCH, 2013, 19 (01) : 268 - 278
  • [43] Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial).
    Varga, Andreea
    Baldini, Capucine
    Martin-Romano, Patricia
    Besse, Benjamin
    Planchard, David
    Champiat, Stephane
    Angevin, Eroc
    Hollebecque, Antoine
    Bahleda, Rastislav
    Gazzah, Anas
    Armand, Jean-Pierre
    Paoletti, Xavier
    Massard, Christophe
    Soria, Jean-Charles
    Marabelle, Aurelien
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
    Varga, Andreea
    Baldini, Capucine
    Martin-Romano, Patricia
    Hollebecque, Antoine
    Gazzah, Anas
    Bahleda, Rastislav
    Menis, Jessica
    Champiat, Stephane
    El-Dakdouki, Yolla
    Paoletti, Xavier
    Ribrag, Vincent
    Michot, Jean-Marie
    Rafie, Saloomeh
    Planchard, David
    Besse, Benjamin
    Massard, Christophe
    Soria, Jean-Charles
    Marabelle, Aurelien
    CANCER RESEARCH, 2018, 78 (13)
  • [45] A Phase I study evaluating the safety, tolerability, and pharmacokinetics of oral vorinostat (VOR) in patients with advanced cancer
    Rubin, Eric H.
    Mazina, Kathryn E.
    Agrawal, Nancy
    Ramakrishnan, Rohini
    Friedman, Evan J.
    Du, Lihong
    Wang, Amy Q.
    Sun, Linda
    Frankel, Stanley R.
    Gottesdiener, Keith M.
    Wagner, John A.
    Iwamoto, Marian
    CANCER RESEARCH, 2006, 66 (08)
  • [46] A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
    Ullenhag, Gustav J.
    Rossmann, Eva
    Liljefors, Maria
    PLOS ONE, 2015, 10 (04):
  • [47] Phase I/Ib dose-escalation study of aveluma in Chinese patients with advanced solid tumors
    Wu, Yi-Long
    Cheng, Ying
    Chen, Huajun
    Tu, Haiyan
    Xu, Chongrui
    Wang, Zhen
    Liu, Ying
    Xin, Ying
    Lou, Haizhou
    Wang, Wei
    Chin, Kevin
    Li, Dandan
    Zhao, Di
    Gao, Yanfei
    Xu, Wenping
    Pan, Hongming
    FUTURE ONCOLOGY, 2022,
  • [48] Phase I dose-escalation study of pasireotide LAR in patients with advanced neuroendocrine tumors.
    Phan, Alexandria T.
    Wolin, Edward M.
    Chan, Jennifer A.
    Huang, Jerry M.
    Hudson, Michelle
    Hughes, Gareth
    Shen, Guoxiang
    Strosberg, Jonathan R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
    Padda, Sukhmani K.
    Krupitskaya, Yelena
    Chhatwani, Laveena
    Fisher, George A.
    Colevas, Alexander D.
    Pedro-Salcedo, Melanie San
    Decker, Rodney
    Latz, Jane E.
    Wakelee, Heather A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1013 - 1020
  • [50] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
12345